229 related articles for article (PubMed ID: 11122592)
21. Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program.
McMahon BJ; Bulkow LR; Singleton RJ; Williams J; Snowball M; Homan C; Parkinson AJ
Hepatology; 2011 Sep; 54(3):801-7. PubMed ID: 21618565
[TBL] [Abstract][Full Text] [Related]
22. Hospital- and community-based screenings for hepatocellular carcinoma in Taiwan.
Kee KM; Lu SN
Oncology; 2011; 81 Suppl 1():36-40. PubMed ID: 22212934
[TBL] [Abstract][Full Text] [Related]
23. Perspectives and control of hepatitis B virus infection in Taiwan.
Lin CL; Kao JH
J Formos Med Assoc; 2015 Oct; 114(10):901-9. PubMed ID: 26184565
[TBL] [Abstract][Full Text] [Related]
24. Rising incidence of hepatitis B-related hepatocellular carcinoma in South Australia: 1996-2010.
Chinnaratha MA; Graham C; Fraser RJ; Woodman RJ; Wigg AJ
Intern Med J; 2016 Aug; 46(8):902-8. PubMed ID: 27130077
[TBL] [Abstract][Full Text] [Related]
25. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study.
Yu MW; Lin CL; Liu CJ; Yang SH; Tseng YL; Wu CF
Gastroenterology; 2017 Oct; 153(4):1006-1017.e5. PubMed ID: 28711626
[TBL] [Abstract][Full Text] [Related]
26. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.
Chen CJ; Yang HI; Su J; Jen CL; You SL; Lu SN; Huang GT; Iloeje UH;
JAMA; 2006 Jan; 295(1):65-73. PubMed ID: 16391218
[TBL] [Abstract][Full Text] [Related]
27. Long-term effectiveness of population-wide multifaceted interventions for hepatocellular carcinoma in Taiwan.
Liao SH; Chen CL; Hsu CY; Chien KL; Kao JH; Chen PJ; Chen TH; Chen CH
J Hepatol; 2021 Jul; 75(1):132-141. PubMed ID: 33689789
[TBL] [Abstract][Full Text] [Related]
28. Rocks along the road to the control of HBV and HCC.
Beasley RP
Ann Epidemiol; 2009 Apr; 19(4):231-4. PubMed ID: 19344859
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B vaccination: disease and cancer prevention-a Taiwanese experience.
Chang MH
Clin Liver Dis; 2010 Aug; 14(3):521-30. PubMed ID: 20638029
[TBL] [Abstract][Full Text] [Related]
30. [Hepatocellular carcinoma: a preventable cancer].
Viviani S; Jack A; Bah E; Montesano R
Epidemiol Prev; 1997; 21(2):129-36. PubMed ID: 9378180
[TBL] [Abstract][Full Text] [Related]
31. Universal HBV vaccination dramatically reduces the prevalence of HBV infection and incidence of hepatocellular carcinoma.
Wong GL; Hui VW; Yip TC; Liang LY; Zhang X; Tse YK; Lai JC; Chan HL; Wong VW
Aliment Pharmacol Ther; 2022 Sep; 56(5):869-877. PubMed ID: 35864571
[TBL] [Abstract][Full Text] [Related]
32. Changing risk factors for hepatocellular carcinoma in hyperendemic regions in the era of universal hepatitis B vaccination.
Wang XY; Huang JM; Lu XM; Harrison TJ; Liu HB; Jia HH; Fang ZL
Cancer Epidemiol; 2020 Aug; 67():101775. PubMed ID: 32623359
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B vaccination and prevention of hepatocellular carcinoma.
Kao JH
Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):907-17. PubMed ID: 26651252
[TBL] [Abstract][Full Text] [Related]
34. Association of Nationwide Hepatitis B Vaccination and Antiviral Therapy Programs With End-Stage Liver Disease Burden in Taiwan.
Chiang CJ; Jhuang JR; Yang YW; Zhuang BZ; You SL; Lee WC; Chen CJ
JAMA Netw Open; 2022 Jul; 5(7):e2222367. PubMed ID: 35849394
[TBL] [Abstract][Full Text] [Related]
35. Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched.
Chien YC; Jan CF; Kuo HS; Chen CJ
Epidemiol Rev; 2006; 28():126-35. PubMed ID: 16782778
[TBL] [Abstract][Full Text] [Related]
36. National antiviral treatment program and the incidence of hepatocellular carcinoma and associated mortality in Taiwan: a preliminary report.
Chang CH; Lin JW; Wu LC; Liu CH; Lai MS
Med Care; 2013 Oct; 51(10):908-13. PubMed ID: 23969591
[TBL] [Abstract][Full Text] [Related]
37. Natural history of chronic hepatitis B REVEALed.
Chen CJ; Yang HI
J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
[TBL] [Abstract][Full Text] [Related]
38. Changing incidence patterns of hepatocellular carcinoma among age groups in Taiwan.
Hung GY; Horng JL; Yen HJ; Lee CY; Lin LY
J Hepatol; 2015 Dec; 63(6):1390-6. PubMed ID: 26256438
[TBL] [Abstract][Full Text] [Related]
39. [Primary prevention by hepatitis B vaccine on liver cancer in high incidence area of China].
Wang YT; Chen TY; Zhu J; Jiao YC; Qu CF
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Apr; 52(4):402-408. PubMed ID: 29614608
[No Abstract] [Full Text] [Related]
40. Hepatocellular carcinoma: an Asian perspective.
Teo EK; Fock KM
Dig Dis; 2001; 19(4):263-8. PubMed ID: 11935085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
